Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference36 articles.
1. Falconer N, Barras M, Martin J, Cottrell N. Defining and classifying terminology for medication harm: a call for consensus. Eur J Clin Pharmacol. 2019;75:137–45. https://doi.org/10.1007/s00228-018-2567-5.
2. Silva LT, Modesto ACF, Amaral RG, Lopes FM. Hospitalizations and deaths related to adverse drug events worldwide: systematic review of studies with national coverage. Eur J Clin Pharmacol. 2022;78:435–66. https://doi.org/10.1007/s00228-021-03238-2.
3. Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999–2006. Ann Pharmacother. 2012;46:169–75. https://doi.org/10.1345/aph.1P592.
4. Funahashi T, Koyama T, Hagiya H, Harada K, Iinuma S, Ushio S, et al. Population-based observational study of adverse drug event-related mortality in the super-aged society of Japan. Drug Saf. 2021;44:531–9. https://doi.org/10.1007/s40264-020-01037-9.
5. US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National action plan for adverse drug event prevention. 2014. https://health.gov/our-work/national-health-initiatives/health-care-quality/adverse-drug-events/national-ade-action-plan. Accessed 10 May 2023.